Can Omega-3s and a prostate drug keep Low-Risk cancer in check?

NCT ID NCT01653925

Ongoing Prevention Sponsor: CHU de Quebec-Universite Laval Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether eating more omega-3 fatty acids (like those in fish oil) and taking a drug called dutasteride can slow the growth of low-risk prostate cancer. The 120 participants are men on active surveillance, meaning their cancer is being watched rather than treated right away. Researchers will check how these interventions affect fat levels and gene activity in the blood and prostate tissue.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: dutasteride and omega-3 fatty acids
What this could lead to: If it works, this could point toward a way to prevent low-risk prostate cancer from progressing, potentially reducing the need for more aggressive treatments.
What could go wrong: This is an early-stage study with only 120 participants, so results may not apply to everyone. The dietary changes and drug may have side effects or show no clear benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LOW GRADE PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer prostate neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LOW GRADE PROSTATE CANCER PROSTATIC NEOPLASMS

Contacts and locations

Locations

Hotel-Dieu of Quebec

Québec, Quebec, G1R 2J6, Canada
Institute of nutraceuticals and functional food of Laval University

Québec, Quebec, G1V 0A6, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.